Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation.
Harada K, Tachibana T, Ohashi K, Ozawa Y, Sawa M, Kondo T, Ishikawa J, Onizuka M, Imada K, Fujisaki T, Tanaka J, Fukuda T, Atsuta Y, Kako S. Harada K, et al. Among authors: kako s. Leuk Lymphoma. 2019 Dec;60(14):3521-3528. doi: 10.1080/10428194.2019.1636986. Epub 2019 Jul 10. Leuk Lymphoma. 2019. PMID: 31290354
Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Okuda S, Terasako K, Oshima K, Sato M, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Kanda Y. Okuda S, et al. Among authors: kako s. Am J Hematol. 2009 Mar;84(3):167-9. doi: 10.1002/ajh.21355. Am J Hematol. 2009. PMID: 19195036 Free article.
Clinical outcome in patients with small-intestinal non-Hodgkin lymphoma.
Kako S, Oshima K, Sato M, Terasako K, Okuda S, Nakasone H, Yamazaki R, Tanaka Y, Tanihara A, Kawamura Y, Kiyosaki H, Higuchi T, Nishida J, Konishi F, Kanda Y. Kako S, et al. Leuk Lymphoma. 2009 Oct;50(10):1618-24. doi: 10.1080/10428190903147629. Leuk Lymphoma. 2009. PMID: 19672778
Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
Ishida Y, Terasako K, Oshima K, Sakamoto K, Ashizawa M, Sato M, Kikuchi M, Kimura S, Nakasone H, Okuda S, Kako S, Yamazaki R, Nishida J, Kanda Y. Ishida Y, et al. Among authors: kako s. Int J Hematol. 2010 Oct;92(3):542-6. doi: 10.1007/s12185-010-0678-6. Epub 2010 Sep 8. Int J Hematol. 2010. PMID: 20824399
A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.
Kako S, Morita S, Sakamaki H, Ogawa H, Fukuda T, Takahashi S, Kanamori H, Onizuka M, Iwato K, Suzuki R, Atsuta Y, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y. Kako S, et al. Leukemia. 2011 Feb;25(2):259-65. doi: 10.1038/leu.2010.260. Epub 2010 Nov 12. Leukemia. 2011. PMID: 21072046
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators. Tauchi T, et al. Leuk Res. 2011 May;35(5):585-90. doi: 10.1016/j.leukres.2010.10.027. Epub 2010 Dec 10. Leuk Res. 2011. PMID: 21145591
304 results